Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
American Journal of Respiratory Cell and Molecular Biology|May 1, 2026
Lytic Cell Death in Chronic Lung DiseasesIoannis Siokas, Morgan Heileman, Lawrence C Fritz, et al.Nature|September 26, 2003
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitorsAdeela Kamal, Lia Thao, John Sensintaffar, et al.Journal of Neurochemistry|October 27, 2006
The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitisCinzia Dello Russo, Paul E Polak, Pilar R Mercado, et al.Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Acyl dipeptides as reversible caspase inhibitors. Part 1: initial lead optimizationSteven D Linton, Donald S Karanewsky, Robert J Ternansky, et al.Journal of Medicinal Chemistry|May 10, 2007
Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activitySrinivas R Kasibhatla, Kevin Hong, Marco A Biamonte, et al.Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Acyl dipeptides as reversible caspase inhibitors. Part 2: further optimizationSteven D Linton, Donald S Karanewsky, Robert J Ternansky, et al.Nature|April 10, 2024
Necroptosis blockade prevents lung injury in severe influenzaAvishekh Gautam, David F Boyd, Sameer Nikhar, et al.Journal of Medicinal Chemistry|October 28, 2005
First-in-class pan caspase inhibitor developed for the treatment of liver diseaseSteven D Linton, Teresa Aja, Robert A Armstrong, et al.Pageof 1